BioCentury
ARTICLE | Company News

Anavex, Israel Institute for Biological Research (IIBR) deal

April 7, 2014 7:00 AM UTC

IIBR's Life Science Research Israel Ltd. subsidiary granted Anavex exclusive, worldwide development and commercialization rights to AF710B and additional backup compounds. The sigma-1 receptor and ...